| Mutations in FLT3 as a therapeutic target |
|
To read the article click here |
A research published this week in the journal Nature, validates certain activating mutations in the FLT3 gene as targets for acute myeloid leukemia therapy -- a critically important finding for developing drugs. An italian researcher, Sara Salerno, working at the Division of Hematology/Oncology, University of California, took part to the research.Participate
Make a donation
Support ISSNAF programs and operations.
Donations to ISSNAF are tax deductible.
Network
Find out who works in your area of expertise or geographic area. ISSNAF Database Search engine allows you to easily view and export contact selections.
Mentorship program
Long and short term mentorships aimed at supporting under-40 ISSNAF affiliates in their career choices and professional growth.
Publish
Send us your texts, videos or podcasts to: publish@issnaf.org
ISSNAF Calendar
Press Room
ISSNAF Reviewers
Register in the ISSNAF Roster of Reviewers of the Italian Ministry of Health Bando Ricerca Finalizzata 2011/12
Partners & Initiatives
More
Social Networking
Issa Wiki
A comprehensive overview on Italian intellectual migration, from its origins in the 16th century until this day.
An encyclopedia studying the influence and contribution of Italians on cultural life in the United States and Canada.
issawiki.org